Peer-reviewed publications

Featured publications
Demand forecasting approaches for new contraceptive technologies: A landscape review and recommendations for alignment

LaCroix E, Jackson A, McGovern S, Rademacher KH, and Rothschild CW.
Global Health: Science and Practice February 2023, 11(1):e2200334;

Introduction of the Ellavi uterine balloon tamponade into the Kenyan and Ghanaian maternal healthcare package

Authors: Parker ME, Qureshi Z, Deganus S, et al.
BMJ Open
February 2023; 13:e066907.

A bilayer microarray patch (MAP) for HIV pre-exposure prophylaxis

Authors: Vora LK, Tekko IA, Zanutto FV, Sabri A, Choy RKM, Mistilis J, Kwarteng P, Jarrahian C, McCarthy HO, Donnelly RF

Pharmaceutics. 2024;16(1):142.

Shigella and childhood stunting: Evidence, gaps, and future research directions.

Authors: Bagamian KH, Anderson JD IV, Blohm G, Scheele S.

PLoS Negl Trop Dis. 2023 Sep 12;17(9):e0011475.

Recent publications

Kumar S, Lennon P, Uranw S, et al.
Using freeze-preventive cold boxes in rural Nepal: A study of equipment performance, acceptability, system fit, and cost.
Vaccine: X. 2024;18:100467.

Vora LK, Tekko IA, Zanutto FV, Sabri A, Choy RKM, Mistilis J, Kwarteng P, Jarrahian C, McCarthy HO, Donnelly RF.
A bilayer microarray patch (MAP) for HIV pre-exposure prophylaxis: the role of MAP designs and formulation composition in enhancing long-acting drug delivery.
Pharmaceutics. 2024;16(1):142.

Williams KL, Guerrero S, Flores-Garcia Y, et al.
A candidate antibody drug for prevention of malaria.
Nat Med 30, 117–129 (2024).

Bagamian KH, Anderson JD IV, Blohm G, Scheele S.
Shigella and childhood stunting: Evidence, gaps, and future research directions.
PLoS Negl Trop Dis. 2023 Sep 12;17(9):e0011475.

Coffey PS, Israel-Ballard K, Meyer L, et al.
The Journey Toward Establishing Inpatient Care for Small and Sick Newborns in Ethiopia, India, Malawi, and Rwanda. 
Glob Health Sci Pract. 2023;11(4):e2200510. Published 2023 Aug 28. doi:10.9745/GHSP-D-22-00510.

Gerth-Guyette E, Nguyen HT, Nowak S, Hoang NT, Mai ĐTT, Thị Sang V, Long NĐ, Mvundura M, Nguyen N, Domingo GJ, Phúc BQ.
Assessing the operational feasibility of integrating point-of-care G6PD testing into plasmodium vivax malaria management in Vietnam.
Pathogens. 2023 May 8;12(5):689. doi: 10.3390/pathogens12050689.PMID: 37242359.

Ashton RA, Hamainza B, Lungu C, Rutagwera MI, Porter T, Bennett A, Hainsworth M, Burnett S, Silumbe K, Slater H, Eisele TP, Miller JM.
Effectiveness of community case management of malaria on severe malaria and inpatient malaria deaths in Zambia.
Malaria Journal 22, Articule number: 96 (March 2023).

Shearer, J.C.; Nava, O.; Prosser, W.; Nawaz, S.; Mulongo, S.; Mambu, T.; Mafuta, E.; Munguambe, K.; Sigauque, B.; Cherima, Y.J.; et al.
Uncovering the drivers of childhood immunization inequality with caregivers, community members and health system stakeholders: Results from a human-centered design study in DRC, Mozambique and Nigeria.
Vaccines 2023, 11, 689.

Werner L, Puta C, Chilalika T, Walker Hyde S, Cooper H, Goertz H, Rivera Hildebrand M, Bernadotte C and Kapnick V
How digital transformation can accelerate data use in health systems.
Front. Public Health March 2023;

Zaman K, Bandyopadhyay AS, Hoque M, Gast C, Yunus M, Jamil KM, Mainou BA, Konopka-Anstadt JL, Hendley WS, Vincent A, Clemens R, Costa Clemens SA, Ross AG, Clemens JD, Tritama E
Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh
The Lancet, Volume 401, Issue 10371, January 2023.

Adigweme I, Futa A, Saidy-Jah E, Edem B, Akpalu E, Dibbasey T, Sethna V, Dhere R, Kampmann B, Bengt C, Sirr J, Hosken N, Goldblatt D, Antony K, Alderson MR, Lamola S, Clarke E
Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trial
The Lancet Infectious Diseases, January 2023.

Doan AH, Vu CMH, Nguyen TT, Green KE, Phan HTT, Janamnuaysook R, Vu BN, Le TM, Do KQ, Tran TT, Ngo TM, Basu L, Tran LK, Humeau Z
Caring for the whole person: transgender-competent HIV pre-exposure prophylaxis as part of integrated primary healthcare services in Vietnam
Journal of the International AIDS Society; 2022, 25(S5):e25996

Birkett A, Miller RS, Soisson LA
The importance of exercising caution when comparing results from malaria vaccines administered on the EPI schedule and on a seasonal schedule
The American Journal of Tropical medicine and Hygiene, Volume 107: Issue 6, December 2022.

Bagamian KH, Puett C, Anderson IV JD, Muhib F, Pecenka C, Behrman J, Breiman RF, Edoka I, Horton S, Kang G, Kotloff KL, Lanata CF, Platts-Mills JA, Qadri F, Rogawski McQuade ET, Sudfeld C, Vonaesch P, Wierzba TF, Scheele S
Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021
Vaccine: X; Volume 12, December 2022.

Limani F, Smith C, Wachepa R, Chafuwa H, Meiring J, Noah P, Patel P, Patel PD, Debellut F, Pecenka C, Gordon M, Bar-Zeev N
Estimating the economic burden of typhoid in children and adults in Blantyre, Malawi: A costing cohort study
PLoS ONE 17(11): e0277419, November 2022.

Debellut F, Tang K, Clark A, Pecenka C, Assao B, Guindo O, Grais RF, Isanaka S
Impact and cost-effectiveness of rotavirus vaccination in Niger: a modelling study evaluating alternative rotavirus vaccines
BMJ Open 2022;12:e061673. October 2022.

Ortiz J R, Robertson J, Hsu J-S, Yu S L, Driscoll A J, Williams S R, Chen W H, Fitzpatrick M C, Sow S, Biellik R J, Neuzil K M.
The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region.
Vaccine. 2021; Volume 39, Issue 15, 8 April 2021.

Polcharee T, Oyen D, Flores-Garcia Y, Gonzalez-Paez G, Han Z, Williams K L, Volkmuth W, Emerling D, Locke E, King C R, Zavala F, Wilson I A
Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum
Nature Communication. 2021; 12(1):1063.

Kannure M, Hegde A, Khungar-Pathni A, Sharma B, Scuteri A, Neupane D, Gandhi R K, Patel H, Surendran S, Jondhale V, Gupta S, Phalake A, Walkar V, George R, McGuire H, Jain N, Vijayan S
Phone calls for improving blood pressure control among hypertensive patients attending private medical practitioners in India: Findings from Mumbai hypertension project
Journal of Clinical Hypertension. 2021 Feb 16. Online ahead of print

Coffey P S, Nguessan A, Agossou A A, Nitiema B C
Enabling demand generation for 7.1% chlorhexidine for umbilical cord care in Togo
Journal of Global Health Reports. 2021; 4:e2020001.

Coffey P S, Kilbourne-Brook M
Using human-centred design to develop an innovative female condom
BMJ Innovatives Published Online First: 07 January 2021.doi: 10.1136/bmjinnov-2020-000534

Vanni T, da Costa Thome B, De Oliveira M M M, Gattas V L, da Graca Salomao M, Koike M E, Lucchesi M B B, Braga P E, de Oliveira Piorellia R, Viscondi J Y K, Mondini G, da Silva A, Espinola H M, do Prado Santos J, de Novoa Rocha S H D, Weckx L Y, Menang O, Soquet M, Precioso A R
Active pharmacovigilance of the seasonal trivalent influenza vaccine produced by Instituto Butantan: A prospective cohort study of five target groups
PLoS One. 2021; 16 (2): e0246540

Chaccour C, Zulliger R, Wagman J, Casellas A, Nacima a, Elobolobo E, Savaio B, Saifodine A, Fornadel C, Richardson J, Candrinho B, Robertson M, Saute F
Incremental impact on malaria incidence following indoor residual spraying in a highly endemic area with high standard ITN access in Mozambique: results from a cluster-randomized study
Malaria Journal 2021; 20 (1): 84.

Clarke E, Bashorun A, Adigweme I, Hydara M B, Umesi A, Futa A, Ochogo M, Obayemi D, Edem B, Saidy-Jah E, Onwuchekwa C, Dhere R, Sethna V, Kampmann B, Goldblatt D, Taylor D, Andi-Lolo I, Hosken N, Antony K, Innis B L, Alderson M R, Lamola S
Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial
Lancet Infectious Disease. 2021 Jan 28; S1473-3099(20)30735-0.

Singh S K, Plieskatt J, Chourasia B K, Fabra-Garcia A, Garcia-Senosiain A, Singh V, Bengtsson K L, Reimer J M, Sauerwein R, Jore M M, Theisen M
A reproducible and scalable process for manufacturing a Pfs48/45 based plasmodium falciparum transmission-blocking vaccine
Frontiers in Immunology. 2021 Jan 11; 11:606266.